
Sep 26 2025 This Week in Cardiology
Om avsnittet
A bold trial in valvular heart disease, a CV prevention trial whose message is humility, VTE dogma challenged, more news on oral GLP-1 agonists, and a few public service announcements are the topics John Mandrola, MD, discusses in this week's podcast.
This podcast is intended for healthcare professionals only.
To read a partial transcript or to comment, visit:
https://www.medscape.com/twic
I DOUBLE-CHOICE: Minimalist Approach to TAVI May Be as Good as Standard of Care https://www.medscape.com/viewarticle/double-choice-minimalist-approach-tavi-may-be-good-standard-2025a1000pp7
- Patient & Physician Perspectives on CV Risk https://www.ahajournals.org/doi/10.1161/CIRCOUTCOMES.124.011837
II KP Vaccinate Trial
- KP Vaccinate Trial https://evidence.nejm.org/doi/full/10.1056/EVIDoa2500208
- IAMI trial https://www.ahajournals.org/doi/10.1161/CIRCULATIONAHA.121.057042
- Increasing Flu Vaccinations in Patients With Chronic Disease https://jamanetwork.com/journals/jama/fullarticle/2824956
- MI FREEE Trial https://www.nejm.org/doi/full/10.1056/NEJMsa1107913
III Hi PRO Trial
- Apixaban for Extended Treatment of VTE https://www.nejm.org/doi/full/10.1056/NEJMoa2509426
- Recurrent VTE in Patients with Provoked VTE https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/226140
IV Oral GLP-1 Agonists
- ATTAIN 1 Trial https://www.nejm.org/doi/full/10.1056/NEJMoa2511774
You may also like:
The Bob Harrington Show with the Stephen and Suzanne Weiss Dean of Weill Cornell Medicine, Robert A. Harrington, MD. https://www.medscape.com/author/bob-harrington
Questions or feedback, please contact [email protected]
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
Fler avsnitt
Visa alla avsnitt av This Week in CardiologyThis Week in Cardiology med Medscape finns tillgänglig på flera plattformar. Informationen på denna sida kommer från offentliga podd-flöden.